2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism
- 1 January 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 9 (4), 581-587
- https://doi.org/10.1093/carcin/9.4.581
Abstract
2-Acetylaminofluorene (AAF), given in the diet at 0.02% for 4 weeks, is an effective promoter of liver carcinogenesis initiated by partial hepatectomy (PH) plus diethylnitrosamine (DEN) in the inbred rat strain Wistar Kyoto. AAF promotes the early (6 week) appearance of phenotypically altered (γ-glutamyltranspeptidase-positive) cells as well as the later appearance of neoplastic nodules (2–4 months) and hepatocarcinomas (4–8 months). Promotion does not seem to involve selective cytotoxkity (selection of AAF-resistant hepatocytes), since neither AAF alone nor DEN+AAF has any inhibitory effect on overall liver growth.This publication has 2 references indexed in Scilit:
- Potent mitogenic activity of 4-acetylaminofluorene to the rat liverMutation Research/Genetic Toxicology, 1986
- Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated ratsExperimental Cell Research, 1985